SuperDimension is a privately-held medical device company that develops and markets minimally-invasive pulmonology devices that enable the diagnosis and potentially the treatment of distal lung disease. Our product line, the iÂ·LogicTM System, includes both capital equipment and disposables, addressing a total available market of more than 8 million patients.
Driven by our mission, "To be the world leader in the diagnosis and treatment of distal lung disease," we are focused on extending the capabilities of traditional bronchoscopy tools to help diagnose previously inaccessible lung lesions at an earlier stage when they may be easier to treat.
Funding Rounds (5) - $75.8MUpdate
Current Team (4)Update
Board Members and Advisors (3)Update
|Mar 10, 2016||Xconomy - NeuWave Bought by J&J Subsidiary Ethicon, Eyes International Markets|
|Feb 16, 2016||PE HUB - Israel Secondary Fund set to close $100 mln fund|
|Aug 20, 2015||globes.co.il - Super Dimension raises $13m - Globes English|
|May 19, 2014||Xconomy - Wisconsin Roundup: Cloud, Solar, Speed Dating, & More|
|Mar 19, 2012||istockanalyst.com - Covidien To Buy Pulmonary Device Maker Superdimension|
|Sep 12, 2011||superdimension.com - SuperDimension raises 11000000 in unknown round|
|Oct 26, 2010||superdimension.com - SuperDimension raises 24800000 in unknown round|
|Sep 7, 2010||FinSMEs - superDimension Raises $24.8M in Debt and Equity Financing|
161 Cheshire Lane, Suite 100
Minneapolis, Minnesota 55441-5433